Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Audentes Therapeutics, Inc. — Taysha Gene Therapies, Inc. insider · InsiderLens

Home / Insiders / Audentes Therapeutics, Inc.

Audentes Therapeutics, Inc.

10% owner at Taysha Gene Therapies, Inc. · on record since Oct 31, 2022

Insider trading activity of Audentes Therapeutics, Inc.

No transactions on record for Audentes Therapeutics, Inc..

Track record of Audentes Therapeutics, Inc.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Audentes Therapeutics, Inc.

Co-insiders of Audentes Therapeutics, Inc.

Alam KamranTaysha Gene Therapies, Inc.
Astellas Pharma Inc.Taysha Gene Therapies, Inc.
DONENBERG PHILIP BTaysha Gene Therapies, Inc.
Long Alison STaysha Gene Therapies, Inc.
Manning Paul BTaysha Gene Therapies, Inc.
Nagendran SukumarTaysha Gene Therapies, Inc.
Nolan Sean P.Taysha Gene Therapies, Inc.
PRASAD SUYASHTaysha Gene Therapies, Inc.
Reape KathleenTaysha Gene Therapies, Inc.
Sepp-Lorenzino LauraTaysha Gene Therapies, Inc.
Session R.A. IITaysha Gene Therapies, Inc.
Stalfort John A IIITaysha Gene Therapies, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters